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Abstract
Objective: To examine the effectiveness of 
an “Enhancing Positive Emotions Procedure” 
(EPEP) based on positive psychology and cog-
nitive behavioral therapy in relieving distress 
at the time of adjuvant chemotherapy treat-
ment in colorectal cancer patients (CRC). It 
is expected that EPEP will increase quality of 
life and positive affect in CRC patients during 
chemotherapy treatment intervention and at 1 
month follow-up. 
Method: A group of 24 CRC patients re-
ceived the EPEP procedure (intervention group), 
whereas another group of 20 CRC patients did 
not receive the EPEP (control group). Quality 
of life (EORTC-QLQC30), and mood (PANAS) 
were assessed in three moments: prior to enter 
the study (T1), at the end of the time required 
to apply the EPEP (T2, 6 weeks after T1), and, 
at follow-up (T3, one-month after T2). Patient’s 
assessments of the EPEP (improving in mood 
states, and significance of the attention re-
ceived) were assessed with Lickert scales. 
Results: Insomnia was reduced in the in-
tervention group. Treatment group had better 
scores on positive affect although there were 
no significantly differences between groups 
and over time. There was a trend to better 
scores at T2 and T3 for the intervention group 
on global health status, physical, role, and 
social functioning scales. Patients stated that 
positive mood was enhanced and that EPEP 
was an important resource.
Resumen
Objetivo: Examinar la eficacia de un pro-
grama basado en la Psicología Positiva y en 
la terapia cognitivo-conductual (EPEP) para 
incrementar emociones positivas y reducir 
malestar en pacientes de cáncer colorrectal 
(CRC) que reciben quimioterapia adyuvante. 
Se espera que el EPEP mejore calidad de vida 
y estados de ánimo durante la quimioterapia y 
en el seguimiento un mes después.
Método: Un grupo de 24 CRC recibió 
el EPEP (grupo de intervención: GI), y otro 
grupo de 20 CRC no recibió el EPEP (grupo 
control: GC). Se evaluaron la calidad de vida 
(EORTC-QLQC30) y los estados de ánimo 
(PANAS) en tres momentos: al entrar en el 
estudio (T1); 6 semanas después, tiempo de 
aplicación del EPEP (T2), y un mes después 
del T2 (seguimiento:T3). Las opiniones de los 
pacientes sobre el EPEP (mejoría del estado de 
ánimo e importancia de la atención recibida) 
fueron evaluadas con escalas Lickert. 
Resultados: El GI mostró mejores puntua-
ciones en estado de ánimo positivo, aunque sin 
diferencias significativas con el GC. Las pun-
tuaciones en T2 y T3 tendían a ser mejores en 
el GI en nivel global de salud, y en las escalas 
física, social y de rol, El GI redujo el nivel de 
insomnio. Los pacientes indicaron que el EPEP 
era importante y mejoraba el estado de ánimo. 
Conclusiones: Los datos sugieren que el 
EPEP mejora el estado de ánimo positivo y la 
calidad de vida, y los pacientes lo consideraron 
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INTRODUCTION
Colorectal cancer (CRC) is the third 
most common cancer in men and the se-
cond in women worldwide. Almost 60% of 
cases occur in developed regions. Deaths 
from colorectal cancer are estimated, 
worldwide, as 8% of all cancer deaths, 
making it the fourth most common cause 
of death from cancer(1). Colorectal cancer 
incidence rates as well as mortality rates 
have been diminishing for most of the past 
two decades. In spite of that, receiving a 
cancer diagnosis represents an enormous 
psychological challenge(2). Cancer and its 
treatment including surgery/chemothera-
py/radiotherapy can also impose a variety 
of physical and functional disabilities that 
compromise the patient’s ability to work 
or to maintain independence(3). Cancer-
related stressors faced by individuals with 
CRC include physical and psychological 
factors of the diagnosis, treatments, side 
effects, reactions of friends/family, follow-
up procedures, and recurrence fears(4). De-
ficits in emotional and social functioning 
and specific limitations like fatigue, dysp-
nea, insomnia, constipation, diarrhea, and 
financial difficulties are main factors ham-
pering the quality of life (QOL) among co-
lorectal cancer patients and seem to affect 
predominantly younger patients(5). 
To assess the impact of disease in indi-
viduals and families, it is important to eva-
luate the quality of life of the patients. The 
quality of life experienced by CRC patients 
is important for evaluating the full impact 
of the disease on individuals and their fa-
milies. There is a need for an intervention 
based on psychological resources that will 
enable patients with cancer to live as po-
sitively as they can with the difficulties of 
a chronic, sometimes debilitating, disease 
and the aversive secondary effects of the 
medical treatment. A promising approach 
is one that focuses on the induction of po-
sitive emotions, especially for the benefits 
which these emotional experiences have 
in the short-term as well as in the medium 
and long-term(6).
In oncology, some interventions that 
include positive psychology elements, 
have displayed encouraging preliminary 
results(7). Although a global consensus of a 
positive therapies classification is needed 
to take one more step in structuring posi-
tive psychology(8), some studies provided 
relevant evidence about the clear develo-
pment of positive aspects from the cancer 
experience, but it is not still well known 
whether positive emotions would improve 
quality of life and disease evolution in CRC 
patients. A recent systematic revision(9) su-
ggests that positive affect (PA) was signi-
ficantly associated with greater levels of 
general health, better social functioning, 
benefit finding, positive changes, low de-
pression, less anxiety and greater psycho-
logical well-being. PA also increases when 
different activities are developed. Howe-
ver, the studies do not provide enough 
evidence about whether cancer stage or 
Conclusions: CRC patients receiving EPEP 
during chemotherapy believed that this interven-
tion was important. Furthermore, EPEP seems to 
improve positive affect and quality of life. EPEP 
has potential benefits, and its implementation to 
CRC patients should be considered.
Keywords: Colorectal Cancer, psychologi-
cal Intervention, positive psychology, cognitive-
behavioral therapy.
importante y útil. El EPEP es potencialmente 
beneficioso y debería considerarse la posibili-
dad de implementarlo en pacientes CRC. 
Palabras Claves: Cáncer Colorrectal, inter-
vención psicológica, psicología Positiva, terapia 
cognitivo-conductual.
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kind of treatment could influence in the 
PA and well-being relationship. Thus, fur-
ther studies which analyse these features 
are needed. We consider that a fruitful 
line of research should be addressed to as-
sess whether a psychological intervention, 
aimed to enhance positive affect, would 
increase quality of life and well-being in 
CRC patients. Furthermore, it would be in-
teresting that this intervention can be easily 
provided to the patients, and applied whi-
le the patient is at the hospital receiving 
medical treatments. In this sense, sessions 
of chemotherapy could be an appropriate 
setting to give patients psychological assis-
tance, since they must remain at hospital 
seated or lying down during several hours. 
Thus, the purpose of this study is to exa-
mine the effectiveness to enhance positive 
affect and quality of life of a Psychologi-
cal Intervention applied at the hospital at 
the same time that patient is receiving his/
her adjuvant chemotherapy schedule. This 
Psychological Intervention has been called 
“Enhancing Positive Emotions Procedure” 
(EPEP) and has been structured from a cog-
nitive behavioral orientation.
METHOD
Participants
All participants were recruited between 
October of 2012 and February of 2014. 
Fifty-two subjects diagnosed with colorec-
tal cancer were recruited at the Portugue-
se Institute of Oncology, Oporto, Portugal. 
These participants had a stage of II and III 
cancer and received the FOLFOX adjuvant 
chemotherapy treatment.
Initially, 107 patients which had those 
characteristics were approached. The flow 
of participants through the study is depic-
ted in Figure 1. Reasons for excluding 57 
Figure 1. Design and Flow Diagram
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Table 1. Distribution of the number and percentage of participants in function of 
the demographic and clinical variables
Intervention Group Control  Group Total
Male Female Male Female Male Female
Total 15(62.5%) 9(37.5%) 14(70%) 6(30%) 29(65.9%) 15(34.1%)
Age
<50 4(26.7%) 2(22.2%) 3(21.4%) 0(0.0%) 7(24.1%) 2(13.3%)
50-59 4(26.7%) 3(33.3%) 3(21.4%) 4(66.7%) 7(24.1%) 7(46.7%)
=>60 7(46.7%) 4(44.4%) 8(57.1%) 2(33.3%) 15(51.7%) 6(40.0%)
Education
Elementary School 
(1-4 grade)
7(46.7%) 4(44.4%) 6(42.2%) 2(33.3%) 13(44.8%) 6(40.0%)
(5-6 grade) 1(6.7%) 1(11.1%) 1(7.1%) 0(0.0%) 2(6.9%) 1(6.7%)
Middle School (7-9 
grade)
3(20.0%) 4(44.4%) 5(35.7%) 3(50.0%) 8(27.6%) 7(46.7%)
Secondary School 
(11-12 grade)
3(20.0%) 0(0.0%) 0(0.0%) 1(16.7%) 3(10.3%) 1(6.7%)
Higher Education 1(6.7%) 0(0.0%) 2(14.3%) 0(0.0%) 3(10.3%) 0(0.0%)
Marital Status
Married 13(86.7%) 3(33.3%) 12(85.7%) 5(83.3%) 25(86.2%) 8(53.3%)
Single 0(0.0%) 2(22.2%) 1(7.1%) 0(0.0%) 1(3.4%) 2(13.3%)
Divorce/Separated 2(13.3%) 2(22.2%) 1(7.1%) 0(0.0%) 3(10.3%) 2(13.3%)
Widowed 0(0.0%) 2(22.2%) 0(0.0%) 1(16,7%) 0(0.0%) 3(20.0%)
Type of cancer
Colon 10(66.7%) 6(66.7%) 9(64.3%) 5(83.3%) 19(65.5%) 11(73.3%)
Rectal 5(33.3%) 3(33.3%) 5(35.7%) 1(15.7%) 10(34.5%) 4(26.7%)
Cancer stage
Stage II 1(6.7%) 2(22.2%) 1(7.1%) 1(16.7%) 2(6.9%) 3(20.0%)
Stage III 14(93.3%) 7(77.8%) 13(92.2%) 5(83.3%) 27(93.1%) 12(80.0%)
cases were: analphabetic (n=1), having a 
prior cancer before actual colorectal can-
cer (n=5), receive other psychiatric or psy-
chological support (n=22), or be receiving 
the 8th to 12th sessions of the FOLFOX 
procedure, since this situation precluded 
the application of the EPEP (see Procedure 
section). One additional man was not eli-
gible since he was deaf. 
Amongst the 52 participants which fi-
nally entered the study, 24 (psychological 
intervention group) completed their pres-
cribed psychological intervention and fo-
llow-up assessment, whereas 20 patients 
(control group) followed the same proce-
dure but without receiving the psycholo-
gical intervention. There were 8 dropouts 
in the study (see figure 1). The reasons for 
dropouts were migration to other hospi-
tals (n = 1), change of medical treatment 
(n = 5), refusal to continue the study (n = 
1), and time constraints (n=1). 
Table 1 shows the distribution of the 
number and percentage of participants and 
their demographic and clinical variables. 
There were no differences between the 
groups in any of demographic and clinical 
variables. 
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Measures
PANAS: We used the Portuguese version 
of the Positive and Negative Affect Schedule 
(PANAS)(10) which consists in a 20 emotions 
checklist with two sub scales, the positive 
affect and the negative affect. The psycho-
metric data analyses resulted in a Portugue-
se version very similar to the original scale, 
sharing 13 items of the 20 from the Ame-
rican scale(11). All the original categories of 
emotion are represented in the Portuguese 
PANAS. Results indicate a good internal 
consistency (α=.86) for the positive affect 
scale and (α=.89) for the negative affect sca-
le. Scores range from 10 – 50, with higher 
scores representing both higher levels for 
positive affect and negative affect. Watson, 
Clark & Tellegan(11) provided mean scores 
of their sample both for momentary and 
weekly affect. For positive affect were 29.7 
(SD=7.9) and 33.3 (SD=7.2) respectively. 
For negative affect, were 14.8 (SD=5.4) and 
17.4 (SD=6.2) respectively.
EORTC QLQ-C30: It was used the Can-
cer Quality of Life Questionnaire Core-30 
(EORTC QLQ-C30, version 3). It is a 30-
item questionnaire, where twenty-four of 
the items form nine multi-item scales and 
six items are single-item symptom measu-
res(12). The scales are constructed by sum-
mation of the scores on the items. Multi-
item subscales and single items intent to 
reflect the multidimensionality of the QoL 
construct(12), namely: five functional subs-
cales (physical, role, cognitive, emotional, 
and social); a global health/QoL subscale; 
three symptom subscales (fatigue, pain, 
and nausea/vomiting); and single items 
for the assessment of additional symptoms 
commonly reported by cancer patients 
(dyspnoea, appetite loss, sleep disturban-
ce, constipation, and diarrhea); one more 
item relates to the perceived financial im-
pact of cancer and cancer treatment, but 
will not be considered in this study. All the 
items scales are scored on 4-point Likert 
type scales ranging from 1 ‘not at all’ to 
4 ‘very much’, except for the two items 
of the global health/QoL subscale, that 
uses a modified 7-point linear analogue 
scales. All of the scales and single item 
scales range in score from 0 to 100. A 
high score for functional scales and global 
health status/QoL represents high/healthy 
level of functioning and QoL. A high score 
for a symptom scale/item represents a high 
level of symptomatology or problems. The 
study of reliability through Cronbach alpha 
shows between 0.74 and 0.88, which is an 
appropriate internal consistency for multi 
item functional and symptom scales. The 
Portuguese version of the QLQC30(13) has 
good metric properties, and measures the 
same constructs, being appropriate to be 
applied to people with cancer disease.
Psychological Treatment Evaluation: Par-
ticipants at the Intervention Group were as-
ked to answer a final questionnaire with the 
following items: 1. To what degree the EPEP 
has improved your positive emotions? 2. To 
what degree the EPEP has improved your 
quality of life? 3. To what degree the EPEP 
has been important to you? All these items 
were measured with a 0-10 numeric scale.
Procedure
The researcher approached all persons 
meeting eligibility criteria. All participants 
were given detailed information by the re-
searcher about the present study. Written 
informed consent was obtained from each 
participant before participation in this stu-
dy. Ethical approval of the study was given 
by the Portuguese Institute of Oncology.
Since the researcher had not enough 
time availability to assess and apply psy-
chological intervention simultaneously to 
both treatment and control groups, it was 
decided to develop the study in two time 
periods. In the first one, patients were assig-
ned to the intervention group until to achie-
ve a sample size of 31 patients. Once the 
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treatment group was completed, the next 
patients were assigned to the control group 
until a sample size of 21 patients was obtai-
ned. Table 2 resumes the procedure applied 
to the patients. Time 2 (T2) assessment was 
applied one month and half after the Time 1 
(T1) assessment, and Time 3 (T3) assessment 
was applied one month after T2. 
Table 2. Structure of sessions applied to treatment and control groups. For each 
session, it is indicated which measures were applied. Characteristics of the 
treatment sessions are specified at the procedure section
PROCEDURE SESSION
TIME 
(Weeks)(*)
CYCLE OF 
CHEMOTHERAPY 
(•)
TREATMENT 
GROUP
CONTROL 
GROUP
ASSESSMENT
(T1) 
Pre-Treatment
PSYCHOLOGICAL 
INTERVENTION FOR 
THE TREATMENT 
GROUP
(EPEP SESSION 1: 
Searching for alternative 
thoughts)
1 0 1-8
PANAS
EORTC
CLINICAL 
VARIABLES
DEMOGRAPHIC 
VARIABLES
PANAS
EORTC
CLINICAL 
VARIABLES
DEMOGRAPHIC 
VARIABLES
PSYCHOLOGICAL 
INTERVENTION FOR 
THE TREATMENT 
GROUP
(EPEP SESSION 2: 
Planning a pleasure 
activity)
2 2 2-9
PANAS PANAS
PSYCHOLOGICAL 
INTERVENTION FOR 
THE TREATMENT 
GROUP
(EPEP SESSION 3: 
Creating positive 
meaning)
3 4 3-10 PANAS PANAS
ASSESSMENT (T2)
Post-treatment
PSYCHOLOGICAL 
INTERVENTION
(SESSION 4: Overview of 
the intervention)
4 6 4-11
PANAS
EORTC
NUMERIC 
SCALE FOR 
EVALUATION 
OF TREATMENT
PANAS
EORTC
ASSESSMENT FOLLOW-
UP (T3)
5 10 5-12
PANAS
EORTC
PANAS
EORTC
(*) Weeks varied between patients, since sometimes the chemotherapy session was delayed because of medical 
reasons. 
(•) the range of Cycles of chemotherapy that patients had received when the session was applied. For example, 
patients who received session 1 at cycle 1 of chemotherapy, received session 2 at cycle 2 and finished their 
participation in the study at cycle 5; patients receiving session 1 at  cycle 5, received session 2 at cycle 6 and 
finished their participation in the study in cycle 9; patients receiving session 1 at cycle 8, received session 2 at 
cycle 9 and finished their participation in the study in cycle 12. 
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On the first period (From September 
2012 to March 2013) participants were in-
vited to participate in study and then were 
successively entering and assigned to the 
EPEP. From September 2013 to December 
2013, patients were invited to participate 
and then successively entering and assigned 
to the control condition. All the participants 
of control group were invited to participate 
in psychological intervention later. The num-
bers of cycles of chemotherapy treatment 
were 12 with an interval of 2 weeks each. 
This adjuvant treatment was given for about 
6 months. Before starting each cycle, pa-
tients were assessed by using the National 
Cancer Institute common toxicity criteria, 
and the results allowed sometimes to delay 
the chemotherapy session. Thus, the time 
between sessions (weeks) was not always 
the same for all patients. Both the inter-
vention and assessment were administrated 
when CRC patients were doing chemothe-
rapy. Participants in both conditions met 
in individual sessions in a room equipped 
with armchairs where chemotherapy (FOL-
FOX) was administered. Patients entered 
the study once the FOLFOX protocol was 
started. Thus, they were recruited between 
their first and eighth sessions of chemothe-
rapy. Although it would be ideal to include 
all patients (both in treatment and control 
groups) just from their first FOLFOX proto-
col this was not possible because of the rea-
sons of time availability for the researcher 
previously stated. Both the intervention and 
assessment were led by the researcher, who 
is a clinical psychologist with professional 
card.
The EPEP is designed to be implemen-
ted during chemotherapy treatment. Its 
features are teaching patients how to a) 
search for positive alternative thoughts; b) 
use activity scheduling and c) create posi-
tive meanings. It is expected that the EPEP 
should be a valuable tool to help them 
cope with the psychological distress asso-
ciated with the diagnosis, stage of disease, 
treatment and its side effects and lack of 
social support. Building patient’s coping 
skills during the treatment might prevent 
depressive and anxiety symptoms and 
maintain or improve quality of life. This 
study attempts to determine if patients at 
the Intervention Group, who will receive 
psychological intervention, improve posi-
tive affect and will preserve or improve 
quality of life greater than patients at the 
Control Group, who will not receive psy-
chological intervention. 
Design
The design of this study was of two 
groups with pre-post-test and follow-up 
comparisons. It was used a cluster sam-
pling by time periods. Pre-tests (T1 as-
sessment) were used to establish baseli-
ne information for the patients´ levels of 
quality of life, and positive and negative 
moods. Post-tests (T2 and T3) were used to 
determine the effects of the interventions 
on quality of life and mood states. 
Data analysis
For each EORTC and PANAS subscales 
it was performed a comparison of means 
with repeated measures applying a Ge-
neral Linear Model (GLM): the treatment 
was a between-subject factor and time of 
evaluation (pre, post and follow-up) was 
within-subject factor. To correct for viola-
tions of sphericity was used Greenhouse-
Geisser correction to produce accurate 
significance (p) value. 
RESULTS
Table 3 shows the mean and SD va-
lues of the subscales of EORTC QLQ-C30 
version 3.0 obtained in intervention and 
control groups in the beginning of the in-
tervention (pre), at the last session (post) 
and at the follow–up. 
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Table 3. Mean and SD of the Scales of EORTC QLQ-C30 for each group 
(intervention and control) and each assessment time (pre, post and follow-up)
Pre (T1) Post (T2) Follow-Up (T3)
Intervention 
(N=24) Control (N=20)
Intervention 
(N=24) Control (N=20)
Intervention 
(N=24) Control (N=20)
Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Global Health 
Status 73.95 17.25 66.25 20.31 77.77 14.88 65.83 16.64 81.59 12.28 66.66 19.68
Functional 
Scales
Physical 
Functioning 89.44 12.26 78.66 14.28 90.00 9.63 80.66 14.96 87.77 12.53 73.00 20.79
Role 
Functioning 92.36 15.52 85.83 21.13 92.36 16.28 85.83 16.46 95.83 10.13 81.66 20.16
Emotional 
Functioning 82.98 13.34 77.50 16.24 85.06 13.45 79.16 19.21 84.72 13.82 71.25 24.25
Cognitive 
Functioning 90.97 12.98 85.00 17.01 92.36 9.80 86.66 17.60 93.75 9.59 88.33 16.31
Social 
Functioning 90.27 13.82 74.16 26.19 91.66 15.54 76.66 25.01 88.19 19.95 75.83 30.81
Symptom 
Scales
Fatigue 10.64 13.30 22.22 16.51 13.42 15.70 26.66 21.14 15.74 16.68 31.66 26.06
Nausea and 
Vomiting 4.86 10.40 2.50 8.15 3.47 6.91 4.16 10.64 4.86 10.40 6.66 13.67
Pain 4.86 10.40 10.00 15.67 3.47 9.80 8.33 12.68 8.33 15.54 11.66 22.36
Dyspnea 1.38 6.80 0.00 0.00 1.38 6.80 3.33 10.25 0.00 0.00 1.66 7.45
Insomnia 22.22 27.21 33.33 35.86 18.05 27.76 36.66 30.39 13.88 19.45 33.33 30.58
Appetite Loss 2.77 9.41 6.66 17.43 5.55 16.05 11.66 19.57 6.94 19.60 11.66 19.57
Constipation 15.00 (N=20) 22.87
10.41
(N=16) 26.44 10.00 19.04 12.50 23.95 5.00 12.21 8.33 19.24
Diarrhea 10.00 (N=20) 15.67
6.25
(N=16) 18.13 8.33 18.33 14.58 20.97 6.66 13.67 10.41 20.06
There were statistically significant di-
fferences between the intervention group 
and control group as a whole on the glo-
bal health status (F= 6.273, p = 0.016), 
on the physical functioning (F= 7.931, p= 
0.007), on the role functioning (F= 4.406, 
p= 0.042) and on the social functioning 
(F= 5.069, p=0.030). However, there were 
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no differences between the three times of 
evaluation and there were not any inte-
raction between treatment and time of 
evaluation. 
In the emotional functioning and cog-
nitive functioning scales, there were not 
statistical differences between groups and 
times of evaluation. There were not any 
interaction between treatment and time of 
evaluation. 
There were statistically significant di-
fferences between the intervention group 
and control group as a whole in the fatigue 
symptom (F= 7.077, p=0 .011), and in the 
insomnia symptom (F= 5.719, p= 0.021). 
However, there were no differences bet-
ween the three times of evaluation and 
there were not any interaction between 
treatment and time of evaluation. There 
were no differences in scores between 
groups for nausea, pain, dyspnea, appetite 
loss, constipation and diarrhea symptoms.
Table 4 shows the mean and SD values 
of the subscales of The Positive and Ne-
gative Affect Schedule (PANAS) obtained 
in intervention and control groups in the 
beginning of the intervention (pre: T1), in-
termedium (int1.), intermedium (int.2) at 
the last session (post: T2) and at the fo-
llow–up (T3). 
In the positive affect there was a diffe-
rence between the intervention group and 
the control group (F= 4.553, p =0.039), 
whit higher scores in the intervention 
group, while there were no differences 
between the five times of evaluation nor 
interaction between treatment and time of 
evaluation. There were not differences in 
scores for negative affect.
Figure 2 shows the number of patients 
who had scores between 0-4, 5-7 and 8-10 
ranges in each of the numeric scales. When 
higher scores (8-10) are considered, almost 
all patients (23/24) gave importance to the 
EPEP, whereas more than 50% stated that 
there was an improvement in PA (15/24) 
and quality of life (13/24). 
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DISCUSSION
For quality of life, the intervention group 
had better scores on global health status, 
physical, role and social functioning sca-
les than control group at all assessments. 
Although this condition does not preclude 
the analysis about whether the EPEP in-
creased quality of life, it would be desi-
rable that both intervention and control 
groups had similar scores at the pretest 
condition. We cannot explain why these 
differences appeared but some considera-
tions could be made. A first explanation 
should consider that positive expectations 
appeared at the intervention group at the 
pretest level: since patients answered the 
EORTC-C30 questionnaire after knowing 
they belonged to a group which will recei-
ve psychological assistance, an optimistic 
bias in scoring items in some scales could 
be appeared. In this sense, it must be poin-
ted out that differences in emotional and 
cognitive functioning scales did not reach 
statistical significance, although mean sco-
res were also higher in the intervention 
group. Thus, this effect should be restricted 
to some areas where patients should be 
more inclined to experience expectations 
of improvement(14). A second explanation 
could be due to the fact that the inter-
vention group was recruited in a different 
period of time than control group and this 
could produce a biased sample. Further-
more, this bias could also be enhanced be-
cause of the small number of participants 
in both groups. 
Whatever the case, and since statis-
tical differences between treatment and 
control conditions in the scores evolu-
tion along the time were not observed, it 
cannot be stated that EPEP improved glo-
bal health status in the treatment group. 
However, a trend to a better condition in 
the global, physical, role and emotional 
scales in the treatment group was obser-
ved. Specially, mean score in treatment 
group at follow-up (81.59) was near the 
upper level of the clinical normal range 
(83.3), and has increased from the mean 
scores at pretest condition (73.95) thus 
suggesting that an improvement in these 
patients has been achieved, since patients 
at the control condition did not change 
mean scores across the three measures 
(66.25, at pretest, and 66.66, at follow-
up). It is possible that EPEP had produced 
slight improvements in patients, which 
6  
  
  
  
Figure 2. Number of Participants who scored into each range of scores for each 
EPEP feature. 
	  
Figure 2. Number of Participants who scored into each 
range of scores for each EPEP feature
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would not be detected by general mea-
sures such as those provided by quality of 
life questionnaires. In fact, studies which 
applied interventions which were based 
on positive psychology procedures, such 
ours, to enhance patients’ conditions (9) 
did not generally use quality of life mea-
sures, whereas the instruments chosen 
were mainly addressed to assess mood 
and emotional states. Thus, perhaps chan-
ges in quality of life measures as a result 
of a brief-intervention procedure such as 
the EPEP, would be difficult to produce, 
since such a result would require longer 
and larger interventions. 
Concerning symptoms scores, the 
means observed in both patient groups 
at pretest and posttest were very low in 
nausea, pain, and dyspnea (lower than 
20 points in a 0-100 points scale) and, 
because of that, they should not be dis-
cussed. The same consideration can be 
stated about diarrhea and constipation 
symptoms. Fatigue and appetite loss 
scores increased across measures and 
this is a normal evolution produced by 
chemotherapy procedures. It is difficult 
to expect that psychological procedures 
should produce better scores in our inter-
vention group when a powerful biological 
agent such as chemotherapy side-effects 
is present. Thus, we think that insomnia is 
the only symptom which should perhaps 
be affected by the EPEP. In fact, we found 
that insomnia was reduced in the inter-
vention group while the control group re-
mained stable. However, as in the global 
health status case, this improvement did 
not reach statistical significance.
In summary, if we consider as a whole 
the Global Health Status and the Physi-
cal, Role, Social functioning, and Insom-
nia Scales, we can see the same evolution, 
suggesting that the intervention group had 
a slightly better condition than control pa-
tients, which could be produced by the 
EPEP. As it has been previously stated, per-
haps these measures and scales are not 
suitable enough for observing the expected 
therapeutic effects. 
Some studies with cancer patients 
found PA of PANAS scores higher than 
those in our sample(15-18); but mean scores 
of NA were very similar. PA is not just the 
flip side of negative affective states. Rather, 
there is increasing support for the idea that 
positive mood and negative mood are re-
lated but distinct constructs(19). In spite of 
that, the mean PA and NA total scores 
were low in comparison with the range 
provided in the original study(11). This can 
be explained because the original range 
provided by Watson et al.(11) was obtained 
in a sample of healthy persons. Furthermo-
re, cultural differences could also produce 
different score levels. Thus, in the study 
of validation of PANAS Scale of the Ko-
rean version, Lim et al.(20) said that they 
had found lower total scores in contrast of 
others studies. These considerations need 
further research in Portuguese populations 
with healthy and non-healthy individuals 
to provide conclusions about whether CRC 
patients had normal or lower PA and NA 
than other persons. 
On the other hand, it must be pointed 
out the fact that the treatment group had 
higher score on positive affect at the five 
times of evaluation in contrast with control 
group although there were no significantly 
differences between groups and over time. 
Although the previous considerations su-
ggest that there was a slightly higher PA 
in the intervention group, which would 
be associated with better quality of life, it 
cannot be concluded, when PANAS sco-
res are considered, that these effects were 
produced by the EPEP. It cannot be ex-
cluded that they could be related to the 
expectations effect mentioned above: pa-
tients at the intervention group could have 
increased their positive emotions because 
of knowing that they would be psychologi-
cally cared, but this fact should not affect 
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negative emotions. It is possible that the 
EPEP was actually effective to produce se-
veral moments of PA in the intervention 
group across sessions which were not ex-
perienced by the control group, but that 
these moments were not reflected at the 
PANAS scores because of the retrospecti-
ve assessment that patients had to make 
to answer the items. If these moments of 
PA were not very frequent and not very 
intense, they would not probably be re-
membered by the patients when answering 
the PANAS, but, at the same time, perhaps 
these PA moments, could have produced 
a “subliminal widespread effect” of bene-
fits which allowed the slight effects of in-
creasing quality of life in the intervention 
group. This hypothesis can be sustained by 
the patients’ comments when describing 
how EPEP intervention improved positi-
ve emotions and increased quality of life. 
Thus, it can be stated, with caution, that 
EPEP should be useful to improve well-
being in CRC patients receiving chemothe-
rapy. Furthermore, participants of inter-
vention group reported they enjoyed and 
benefited from their therapeutic experien-
ce when they were asked to evaluate the 
psychological intervention.
Some limitations of the study must be 
pointed out: The number of patients par-
ticipating in this research does not allow 
the assumption of normality distribution 
of scores in the different features assessed. 
Thus, generalizations from this research 
study may not be appropriate and should 
be used with caution. Because we had not 
enough resources to develop a randomized 
study, we developed a non-randomized 
clinical trial study, with its constraints to 
achieve control over the confusing varia-
bles. Furthermore, although it was expec-
ted that both groups were similar at pretest 
measures, this condition was not always 
satisfied. Thus, it must be taken with cau-
tion that between groups differences could 
be produced by the EPEP. 
Results offered by the present research 
are not conclusive, as it can be expected 
from a pilot study, but suggest that the 
EPEP can actually be useful and suitable 
for CRC patients since they can receive 
the EPEP at the same time they are fo-
llowing their medical schedules. It can be 
considered that EPEP did not allow hig-
her effects because the procedure could 
not be applied in its optimal pattern to 
all patients at the intervention group (for 
example, time between EPEP sessions was 
too long in some cases because of the 
delays in applying chemotherapy when 
patients did not reach medical conditions 
required for receiving chemotherapy). On 
the other hand, maybe EPEP is too short, 
since other interventions in cancer pa-
tients use a higher number of therapeutic 
sessions than those provided by our EPEP 
(9). Further research is needed to confirm 
that a wider schedule of the EPEP would 
produce higher improvements in PA and 
NA in CRC patients.
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